Stocktoria
TALPHERA, INC. TLPH
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2011-02-11
TALPHERA, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $28,000 | $0 | $651,000 | $0 | $2.8M |
| R&D expense | $6.0M | $6.7M | $5.5M | $3.3M | $4.1M |
| SG&A expense | $7.5M | $8.5M | $12.0M | $17.0M | $30.9M |
| Operating income | -$13.5M | -$15.3M | -$16.9M | -$25.3M | -$36.0M |
| Interest expense | — | — | $134,000 | $1.1M | $2.3M |
| Income tax | $0 | $0 | $0 | $13,000 | $5,000 |
| Net income | -$14.3M | -$13.0M | -$18.4M | $47.8M | -$35.1M |
| EPS (diluted) | — | — | $-1.29 | $5.72 | $-5.86 |
| Operating cash flow | -$11.4M | -$12.7M | -$17.5M | -$28.3M | -$30.0M |
| Free cash flow | — | -$12.7M | -$17.6M | -$28.7M | -$31.8M |
| Cash & equivalents | $5.9M | $8.9M | $5.7M | $15.3M | $7.7M |
| Inventory | — | — | — | $1.2M | $1.1M |
| Total assets | $29.7M | $18.2M | $20.4M | $47.5M | $77.9M |
| Total liabilities | $12.7M | $10.2M | $6.3M | $25.7M | $113.8M |
| Shareholders' equity | $17.0M | $8.0M | $14.1M | $21.8M | -$35.9M |
Source: SEC EDGAR filings · CIK 0001427925 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.